Accessibility Menu
 
Treace Medical Concepts logo

Treace Medical Concepts

(NASDAQ) TMCI

Current Price$2.67
Market Cap$172.56M
Since IPO (2021)-90%
5 Year-91%
1 Year-61%
1 Month+19%

Treace Medical Concepts Financials at a Glance

Market Cap

$172.56M

Revenue (TTM)

$207.32M

Net Income (TTM)

$61.04M

EPS (TTM)

$-0.96

P/E Ratio

-2.78

Dividend

$0.00

Beta (Volatility)

1.33 (Average)

Price

$2.67

Volume

689,711.782

Open

$2.64

Previous Close

$2.66

Daily Range

$2.57 - $2.81

52-Week Range

$1.17 - $7.78

TMCI: Motley Fool Moneyball Superscore

51

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Treace Medical Concepts

Industry

Healthcare Equipment and Supplies

Employees

450

CEO

John T. Treace

Headquarters

Ponte Vedra, FL 32081, US

TMCI Financials

Key Financial Metrics (TTM)

Gross Margin

80%

Operating Margin

-27%

Net Income Margin

-29%

Return on Equity

-67%

Return on Capital

-37%

Return on Assets

-33%

Earnings Yield

-35.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$172.56M

Shares Outstanding

64.87M

Volume

689.71K

Avg. Volume

835.59K

Financials (TTM)

Gross Profit

$169.75M

Operating Income

$54.15M

EBITDA

$43.18M

Operating Cash Flow

$15.97M

Capital Expenditure

$13.52M

Free Cash Flow

$29.49M

Cash & ST Invst.

$48.37M

Total Debt

$13.98M

Treace Medical Concepts Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$47.20M

-10.2%

Gross Profit

$37.41M

-10.7%

Gross Margin

79.26%

N/A

Market Cap

$172.56M

N/A

Market Cap/Employee

$361.77K

N/A

Employees

477

N/A

Net Income

$17.96M

-12.8%

EBITDA

$16.27M

-33.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$38.30M

+469.6%

Accounts Receivable

$30.36M

-2.4%

Inventory

$36.37M

-4.1%

Long Term Debt

$13.55M

-79.9%

Short Term Debt

$0.00

-100.0%

Return on Assets

-33.16%

N/A

Return on Invested Capital

-37.26%

N/A

Free Cash Flow

$4.17M

+536.9%

Operating Cash Flow

$7.23M

+72.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RXSTRxSight, Inc.
$5.97+5.11%
SMLRSemler Scientific, Inc.
$20.33-4.87%
LABStandard BioTools Inc.
$0.99+0.73%
TOIThe Oncology Institute, Inc.
$3.92-1.63%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$14.02-0.07%
POETPoet Technologies
$13.73-0.14%
FFord Motor Company
$13.05-0.03%
IBITiShares Bitcoin Trust
$43.25-0.04%

Questions About TMCI

What is the current price of Treace Medical Concepts?

Treace Medical Concepts is trading at $2.65 per share.

What is the 52-week range for Treace Medical Concepts?

Over the past 52 weeks, Treace Medical Concepts has traded between $1.17 and $7.78.

How much debt does Treace Medical Concepts have?

As of the most recent reporting period, Treace Medical Concepts reported total debt of $71.60M.

How much cash does Treace Medical Concepts have on hand?

Treace Medical Concepts reported $9.54M in cash and cash equivalents in its most recent financial results.

What is Treace Medical Concepts’s dividend yield?

Treace Medical Concepts does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.